Sou Hu Cai Jing·2026-02-26 19:33Core Viewpoint - Southbound funds reduced their holdings in Fosun Pharma (02196.HK) by 52,000 shares on February 26, while net purchases occurred on 3 out of the last 5 trading days, totaling 514,000 shares [1] Group 1: Southbound Fund Activity - Over the last 20 trading days, Fosun Pharma experienced net purchases from southbound funds on 11 days, accumulating a total of 229,500 shares [1] - Currently, southbound funds hold 319 million shares of Fosun Pharma, representing 57.76% of the company's total issued ordinary shares [1] Group 2: Company Overview - Shanghai Fosun Pharmaceutical (Group) Co., Ltd. primarily engages in the research, development, manufacturing, and sales of pharmaceutical products [1] - The company operates through five segments: - The pharmaceutical segment focuses on innovative drugs, mature pharmaceutical products, and vaccines - The medical devices and diagnostics segment manufactures and sells molecular diagnostics, immunodiagnostics, and microbiological diagnostic devices - The healthcare services segment operates an integrated online and offline medical service platform - The pharmaceutical distribution and retail segment is involved in the wholesale and retail of pharmaceutical products - Other segments engage in various pharmaceutical-related businesses [1] - The company's products are mainly used in the treatment fields of oncology, immunology, and central nervous system disorders [1]